Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Spinal Endocannabinoids and CB1 Receptors Mediate C-Fiber–Induced Heterosynaptic Pain Sensitization
Alejandro J. Pernía-Andrade,1,*,
Ako Kato,1,9,*
Robert Witschi,1,9,*
Rita Nyilas,2
István Katona,2
Tamás F. Freund,2
Masahiko Watanabe,3
Jörg Filitz,4
Wolfgang Koppert,4,
Jürgen Schüttler,4
Guangchen Ji,5
Volker Neugebauer,5
Giovanni Marsicano,6
Beat Lutz,7
Horacio Vanegas,8
Hanns Ulrich Zeilhofer1,9,
Abstract:
Diminished synaptic inhibition in the spinal dorsal horn isa major contributor to chronic pain. Pathways that reduce synapticinhibition in inflammatory and neuropathic pain states havebeen identified, but central hyperalgesia and diminished dorsalhorn synaptic inhibition also occur in the absence of inflammationor neuropathy, solely triggered by intense nociceptive (C-fiber)input to the spinal dorsal horn. We found that endocannabinoids,produced upon strong nociceptive stimulation, activated type1 cannabinoid (CB1) receptors on inhibitory dorsal horn neuronsto reduce the synaptic release of -aminobutyric acid and glycineand thus rendered nociceptive neurons excitable by nonpainfulstimuli. Our results suggest that spinal endocannabinoids andCB1 receptors on inhibitory dorsal horn interneurons act asmediators of heterosynaptic pain sensitization and play an unexpectedrole in dorsal horn pain-controlling circuits.
1 Institute of Pharmacology and Toxicology, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland. 2 Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1083 Budapest, Hungary. 3 Department of Anatomy, Hokkaido University School of Medicine, Sapporo 060-8638, Japan. 4 Department of Anesthesiology, University of Erlangen-Nürnberg, Krankenhausstrasse 12, D-91054 Erlangen, Germany. 5 Department of Neuroscience and Cell Biology, University of Texas Medical Branch, Galveston, TX 77555–1069, USA. 6 U862 Centre de Recherche INSERM François Magendie, 33077 Bordeaux, France. 7 Institute of Physiological Chemistry and Pathobiochemistry, Johannes Gutenberg-University Mainz, D-55099 Mainz, Germany. 8 Instituto Venezolano de Investigaciones Cientificas, Apartado 20632, Caracas 1020A, Venezuela. 9 Institute of Pharmaceutical Sciences, ETH Zurich, Wolfgang Pauli Strasse 10, CH-8093 Zurich, Switzerland.
* These authors contributed equally to this work.
Present address: Institute of Physiology, University of Freiburg,Engesserstrasse 4, D-79108, Freiburg, Germany.
Present address: Department of Anesthesiology, Medical SchoolHannover, D-30625 Hannover, Germany.
To whom correspondence should be addressed. E-mail: zeilhofer{at}pharma.uzh.ch
The editors suggest the following Related Resources on Science sites:
In Science Signaling
PERSPECTIVES
MacDonald J. Christie and Christophe Mallet (15 September 2009) Sci. Signal.2 (88), pe57.
[DOI: 10.1126/scisignal.288pe57] |Abstract »|Full Text »|PDF »
EDITORS' CHOICE
Peter R. Stern (11 August 2009) Sci. Signal.2 (83), ec269.
[DOI: 10.1126/scisignal.283ec269] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Genome-Wide Expression Analysis of Ptf1a- and Ascl1-Deficient Mice Reveals New Markers for Distinct Dorsal Horn Interneuron Populations Contributing to Nociceptive Reflex Plasticity.
H. Wildner, R. Das Gupta, D. Brohl, P. A. Heppenstall, H. U. Zeilhofer, and C. Birchmeier (2013)
J. Neurosci.
33, 7299-7307
|Abstract »|Full Text »|PDF »
Why do cannabinoid receptors have more than one endogenous ligand?.
V. Di Marzo and L. De Petrocellis (2012)
Phil Trans R Soc B
367, 3216-3228
|Abstract »|Full Text »|PDF »
Dynamic changes to the endocannabinoid system in models of chronic pain.
D. Rani Sagar, J. J. Burston, S. G. Woodhams, and V. Chapman (2012)
Phil Trans R Soc B
367, 3300-3311
|Abstract »|Full Text »|PDF »
Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system.
Endocannabinoid-dependent plasticity at spinal nociceptor synapses.
A. Kato, P. Punnakkal, A. J. Pernia-Andrade, C. von Schoultz, S. Sharopov, R. Nyilas, I. Katona, and H. U. Zeilhofer (2012)
J. Physiol.
590, 4717-4733
|Abstract »|Full Text »|PDF »
Cannabinoids suppress inflammatory and neuropathic pain by targeting {alpha}3 glycine receptors.
W. Xiong, T. Cui, K. Cheng, F. Yang, S.-R. Chen, D. Willenbring, Y. Guan, H.-L. Pan, K. Ren, Y. Xu, et al. (2012)
J. Exp. Med.
209, 1121-1134
|Abstract »|Full Text »|PDF »
Gating the Polarity of Endocannabinoid-Mediated Synaptic Plasticity by Nitric Oxide in the Spinal Locomotor Network.
J. Song, A. Kyriakatos, and A. El Manira (2012)
J. Neurosci.
32, 5097-5105
|Abstract »|Full Text »|PDF »
Fast Synaptic Inhibition in Spinal Sensory Processing and Pain Control.
H. U. Zeilhofer, H. Wildner, and G. E. Yevenes (2012)
Physiol Rev
92, 193-235
|Abstract »|Full Text »|PDF »
mGluR1, but not mGluR5, activates feed-forward inhibition in the medial prefrontal cortex to impair decision making.
Mitochondrial Reactive Oxygen Species Are Activated by mGluR5 through IP3 and Activate ERK and PKA to Increase Excitability of Amygdala Neurons and Pain Behavior.